Trademark: 87975695
Word
CASEBIA
Status Date
Friday, April 5, 2024
Registration Number
5298341
Registration Date
Tuesday, September 26, 2017
Filing Date
Thursday, June 23, 2016
Published for Opposition
Tuesday, December 13, 2016
Cancellation Date
Friday, April 5, 2024
42 Research and development of human therapeutics using gene editing; pharmaceutical research and development services
Oct 4, 2016
Examiners Amendment -Written
Jun 27, 2016
New Application Entered
Jun 29, 2016
New Application Office Supplied Data Entered
Sep 29, 2016
Assigned To Examiner
Oct 4, 2016
Notification Of Examiners Amendment E-Mailed
Oct 4, 2016
Examiners Amendment E-Mailed
Nov 5, 2016
Law Office Publication Review Completed
Oct 4, 2016
Examiner's Amendment Entered
Oct 18, 2016
Approved For Pub - Principal Register
Oct 30, 2016
Assigned To Lie
Nov 23, 2016
Notification Of Notice Of Publication E-Mailed
Dec 13, 2016
Published For Opposition
Dec 13, 2016
Official Gazette Publication Confirmation E-Mailed
Feb 7, 2017
Noa E-Mailed - Sou Required From Applicant
Aug 10, 2017
Divisional Processing Complete
Aug 10, 2017
Statement Of Use Processing Complete
Jul 17, 2017
Sou Teas Extension Received
Jul 17, 2017
Teas Request To Divide Received
Jul 17, 2017
Teas Statement Of Use Received
Jul 17, 2017
Sou Extension 1 Filed
Jul 17, 2017
Divisional Request Received
Aug 7, 2017
Case Assigned To Intent To Use Paralegal
Aug 10, 2017
Sou Extension 1 Granted
Jul 17, 2017
Use Amendment Filed
Aug 19, 2017
Notice Of Acceptance Of Statement Of Use E-Mailed
Sep 26, 2017
Registered-Principal Register
Sep 26, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Apr 5, 2024
Cancelled Sec. 8 (6-Yr)
Apr 9, 2018
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 11, 2017
Notice Of Approval Of Extension Request E-Mailed
Aug 18, 2017
Allowed Principal Register - Sou Accepted
Apr 9, 2018
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Trademark Alertz updated from USPTO on 2030-01-24
